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 Abstract
The GABAB receptor is a member of the ‘‘family 3’’ G protein coupled receptors. The
GABAB receptors modulate activity inwardly rectifying potassium channels and high
voltage activated calcium channels. The GABAB receptors require heterodimerization
between two subunits, GABAB1 and GABAB2, for functional expression. A robust func-
tional calcium cell line was developed that contained both the human truncated
GABAB(1b) and human truncated GABAB(2) receptors. The cell line was analyzed and
sorted using b-lactamase as a reporter. Single cell clones were sorted and isolated using
flow cytometry based on high b-lactamase expression. The single cell clones were fur-
ther tested in a 384-well calcium mobilization assay using the Fluo-4 AM calcium indi-
cator on the fluorescent imaging plate reader system (FLIPR). Twenty-seven clones
were grown up from single cell collections and 10 clones demonstrated a high response
to GABA stimulation. The 10 clones were re-evaluated based on agonist dose response
and EC50. Clone-16 was identified and utilized in high throughput screening (HTS)
assay development. Using sorting and b-lactamase as a reporter, we were able to de-
velop a robust, functional cell-based, GABAB, calcium mobilization assay. The cell line
described here can be used for high throughput FLIPR screening and also to compare
and rank the potency and selectivity of agonists, antagonists and potentiators of the
GABAB receptor. ' 2008 International Society for Advancement of Cytometry
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GABAB receptors are metabotropic transmembrane receptors for gamma-amino-
butyric acid (GABA) that are linked via G-proteins to potassium channels (1). These
receptors are found in the central and peripheral autonomic nervous system (2).
There are two subtypes of the receptor, GABAB1 and GABAB2, which need to assem-
ble as a heterodimer to be functional (3,4). The GABAB1 subunit consists of the
extracellular binding site, whereas the GABAB2 subunit mediates G-protein coupled
signaling (5,6). The two subunits assemble and interact allosterically, such that
GABAB2 increases the affinity of GABAB1 for agonists and GABAB1 facilitates the
coupling of GABAB2 to G-proteins (6,7). The activation of GABAB causes an inhibi-
tion of adenylate cyclase activity together with a decrease in calcium or inwardly rec-
tifying potassium channels (3). This activation prevents sodium channels from open-
ing, and thus inhibits neurotransmitter release.
The G protein-coupled GABAB receptor was described over 20 years ago yet
only recently has been cloned (2). With this, has come the identification of its unique
heterodimeric structure. It is crucial to determine if GABAB receptor subtypes exist,
and whether or not they can be exploited pharmacologically to determine if other
proteins or small molecules can bind with GABAB1 to form a functional receptor, to
establish whether the receptor has other cellular functions, and to assess the clinical
value of GABAB agonists, antagonists, and positive allosteric modulators.
The ability to screen millions of compounds in a chemical library to identify
potential drug candidates is a valuable asset for any pharmaceutical drug research
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and development program. The calcium flux assay is the most
popular high throughput screening approach because it is a
rapid and direct signal for biological activity of GPCRs. The
measurement of intracellular calcium response in cells is a
popular functional assay for GPCRs.
The FLIPR system allows for the rapid and kinetic deter-
mination of the rise in cytosolic calcium levels using cell per-
meable calcium sensing fluorescent indicators such as Fluo-4
AM (8). The FLIPR was developed as a high throughput
screening instrument for cell-based, fluorescent screening (9).
The FLIPR system is unique because it can read all the wells of
a 96, 384, or 1,536-well microplate simultaneously, with ki-
netic updates in under a second (9,10). The FLIPR assay has
become one of the primary assays for measuring GPCR func-
tion because it is amenable to robotic automation and minia-
turization to 1,536-well microplates (10).
To develop a sensitive and robust high throughput
screening cell line the reporter must be compatible with flow
cytometry and sorting. The success of developing a cell-based
assay depends entirely on the quality of the reporter gene. b-
lactamase is an ideal reporter system for monitoring gene
expression in live cells (11). b-lactamase is a reporter system
that can be used to monitor gene expression and is also
amendable for flow cytometry and sorting (12,13). Neither the
b-lactamase enzyme nor the CCF4 AM substrate is toxic to
live cells and thus can be used to rapidly develop stably trans-
fected clonal cell lines (12,13). b-lactamase provides a reliable
marker for gene expression in a variety of cell types, and can
be used with flow cytometry to isolate low and high expressing
clonal populations (13).
The coexpression of G-proteins with Gq chimeras allows
for the measurement of the calcium response through the Gq
pathway (14–16). A cell line was developed that contains both
GABAB1 and GABAB2 receptors, which were cloned and coex-
pressed in Gqi3 (5), containing CHO cells (Fig. 1). The cell
line was analyzed and sorted using b-lactamase as a reporter.
GABAB receptor activation triggers calcium signaling through
the binding and activation of G-proteins and b-lactamase
expression is activated from the NFat response element upon
stimulation of Gq-coupled receptors. Single cell clones were
sorted and isolated using flow cytometry based on high b-lac-
tamase expression. High responders expressing GABAB recep-
tor clones were further tested and evaluated on the FLIPR.
Using an isolated single-cell clone, a sensitive FLIPR, calcium-
based functional assay has been established and validated.
MATERIALS AND METHODS
Materials and Reagents
The b-lactamase substrate CCF4-AM, the cell culture and
molecular cloning reagents were purchased from Invitrogen
(Carlsbad, CA). Propidium iodide (PI) and the calcium indi-
cator Fluo-4 AM were purchased from Molecular Probes
(Eugene, OR). GABA was purchased from Sigma (St. Louis,
MO), and the GABAB antagonist CGP54626 was purchased
form Tocris Bioscience (Ellisville, MO). The 384-well clear
bottom black plates were purchased from VWR (West Chester,
PA).
Plasmid Construction
GABAB receptors without the intracellular coiled-coil
domains were designed and used. Truncated human GABAB1b
and truncated human GABAB2 were cloned from the human
whole brain cDNA library from BD Bioscience, (San Jose, CA)




AT-30; GABAB2 primers, 50-ACCACCATGGCTTCCCCGCGA
AGCTCCGGG-30 and 50-TTAGACCGAGGTGGACGTTTTAG
AATC-30. The PCR products were then cloned into the
pcDNA3.1 vector using the TOPO cloning kit from Invitrogen
(Carlsbad, CA). The resulting plasmid DNAs were checked by
restriction enzyme digestions and the correct plasmids were
confirmed by sequencing (see supplementary materials for full
length sequences). While the C-terminal domains of GABAB
Figure 1. Schematic illustration of the GABAB signaling pathway
and the use of CCF4 AM or Fluo-4 AM to monitor calcium mobili-
zation or b-lactamase expression. The GABAB1 subunit consists of
the extracellular binding site, whereas the GABAB2 subunit med-
iates G-protein coupled signaling. The two subunits assemble
and interact allosterically, such that GABAB2 increases the affinity
of GABAB1 for agonists and GABAB1 facilitates the coupling of
GABAB2 to G-proteins. GABAB receptor activation triggers calcium
signaling through the binding and activation of G-proteins. b-lac-
tamase expression is activated from the calcium sensitive NFat
response element (NFat bla). Fluo-4 AM is a green fluorescent in-
dicator, which exhibits a calcium dependent increase in fluores-
cence emission upon calcium binding. CCF4 AM is a fluorescent
resonance energy transfer based substrate for b-lactamase. b-lac-
tamase cleaves CCF4 AM disrupting the FRET resulting in a
change of fluorescence from green to blue.
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subunits mediate intracellular trafficking, they are not essen-
tial for heterodimeric assembly and receptor signaling. In this
study, we used truncated forms of both GABAB1 and GABAB2
receptors to promote cell surface expression and formation of
a functional heterodimer at the cell surface.
Transfections
Plasmid DNA encoding truncated GABAB(1b) and that
encoding truncated GABAB(2) were cotransfected into CHO-
Gqi3 (5)-NFat-b-lactamase cells (Aurora Biosciences, San
Diego, CA) using electroporation. Cells were grown in T75
flask to confluence in DMEM medium supplemented with 25
mM HEPES, 13 NEAA, 10% dFBS, 100 lg/ml Zeocin, and
2.5 lg/ml blasticindin. The cells were then detached, and 20
lg of each DNA were added to 10 E 7 cells in 0.8 ml of serum
free medium in an electroporation chamber. After electropora-
tion, cells were diluted and grown in the above medium with
geneticin at 1 mg/ml. After 10 days, most cells died and the
remaining resistant cells were sorted using flow cytometry.
Flow Cytometry Analysis and Sorting
Flow cytometric analysis was performed using a FACS-
Vantage SE flow cytometer (Becton Dickinson Immunocyto-
metry Systems, San Jose, CA) equipped with an Enterprise II
laser and an Innova 302C Krypton Ion Laser (Coherent, Santa
Clara, CA). The 488-nm line was positioned as the primary
laser beam, and the 407-nm line was positioned in the second-
ary laser position. Propidium iodide was excited at 488 nm,
and the emission of propidium iodide was measured using a
675 nm bandpass filter, and a 650 dichroic short pass filter.
CCF4 AM was excited at 407 nm, and the emission of CCF4
AM was measured using a 525 nm bandpass filter (green chan-
nel) and a 460 nm bandpass filter (blue channel). A 490 nm
dichroic long pass filter was used to separate the signals. Viable
cells were gated based on the absence of detectable incorpora-
tion of propidium iodide. Singlets were selected using forward
scatter peak versus forward scatter width signals. High b-lacta-
mase expressing cells were sorted based on bright blue fluores-
cence and low green fluorescence. Twenty-five thousand (25k)
gated events were counted for each sample.
FLIPR Analysis
The fluorescence imaging plate reader (FLIPR) analysis
was performed on the FLIPR 384 system (Molecular Device,
Sunnyvale, CA). The GABAB stable cell line was maintained in
DMEM medium, with 25 mM HEPES, 5% dFBS, 13 NEAA,
100 lg/ml zeocin, 2.5 lg/ml blastocidin, and 500 lg/ml genet-
icin. Twenty-four hours prior to the experiment, the cells were
plated in the 384-well clear-bottom black-well plate at the
density of 15k cells/well in the above medium without antibio-
tics. On the day of the experiment, cells were washed with
assay buffer (HBSS, with 20 mM HEPES and 2.5 mM probe-
necid), and then loaded with Fluo-4 AM for 60 min at 378 C.
The cells were washed again with the assay buffer and 30 ll
volume was left in each well. All compounds were diluted to
the desired concentration in the assay buffer. The cell plates
were then analyzed on the FLIPR. Normal FLIPR-384 instru-
ment settings were used with the exception of laser power
which was set to 600 MW power to reduce the signal of the
calcium response to get the fluorescence signal on-scale.
Data Analysis
In the FLIPR software, spatial uniformity correction,
baseline subtraction, and maximum fluorescence change were
used.
RESULTS
In the GABAB cell line, we can measure calcium mobiliza-
tion using Fluo-4 AM and b-lactamase expression using CCF4
AM. The GABAB receptor activation triggers calcium signaling
through the binding and activation of G-proteins. b-lactamase
is expressed through the activation of the NFat response ele-
ment through the Gq-coupled receptors mobilization of cal-
cium. Fluo-4 AM is a green fluorescent indicator that exhibits
a calcium dependent increase in fluorescence emission upon
calcium binding. CCF4 AM is a fluorescent resonance energy
transfer based substrate for b-lactamase. b-lactamase cleaves
CCF4 AM, disrupting the FRET, which causes a change of flu-
orescence from green to blue (Fig. 1).
Following transfection, the cells were analyzed and sorted
based on the expression of b-lactamase. The purpose of the
first sort was to identify a pool of cells that responded to
GABA. The cells were treated with either 200 lM GABA, 200
nM thapsigargin, or vehicle for 4 h and loaded with CCF4
AM. In comparison with the vehicle population, the treated
group demonstrated a low change in b-lactamase expression.
This small fraction of cells, which consisted of a bright-blue
and low-green fluorescence population (upper left quan-
drant), was identified and sorted (Fig. 2). Thapsigargin can
increase the cytosolic concentration of calcium by opening
IP3-gated channels in the ER and by activating plasma mem-
brane calcium channels, allowing an influx of calcium into the
cytosol without signaling through the GABAB receptor. The
thapsigargin control showed a robust response at 200 nM.
The sorted pool of cells were expanded and reanalyzed
for b-lactamase expression following stimulation of GABA.
The sorted pool of cells demonstrated a four-fold increase in
the percentage of cells of the highest b-lactamase expressing
cells over the vehicle group. This high b-lactamase expressing
population was identified and sorted for single cell clones to
isolate a clonal GABAB cell line (Fig. 3). The sorted pool of
cells showed a robust response when treated with 200 nM
thapsigargin.
The clonal cell lines were expanded and seeded into a 384
well plate, loaded with Fluo-4 AM, and analyzed on the
FLIPR. Twenty-seven clones were grown from single cell col-
lections and 10 clones demonstrated a high response to GABA
stimulation, compared with the sorted pool of cells. The 10
clones were re-evaluated based on GABA dose response and
EC50. Clone-16 was identified and utilized in high throughput
assay development (Fig. 4). We found that many clones had a
robust signal in the FLIPR assay. Several of the high response
clones were further evaluated, and clone 16 consistently
showed a robust assay window.
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Twenty-four hours prior to the experiment, clone-16 cells
were seeded into a 384 well plate at 15k cells/well. Cells were
loaded with Fluo-4 AM and analyzed on the FLIPR. GABA
was added to the well 6 s after the start of data acquisition.
The average FLIPR well response (16 wells/trace) to a GABA
serial dilution is shown in Figure 5. The EC50 for the GABA
serial dilution is 45.3 nM (Fig. 6). CGP54626 (GABA antago-
nist) was added to the well 5 min prior to the addition of 100
nM GABA. The average FLIPR well response (16 wells/trace)
to a CGP54626 serial dilution was calculated. The IC50 for the
CGP54626 serial dilution is 3.57 nM (Fig. 7). There was no
response of the parental cell line (no GABA-receptor) to
GABA (data not shown).
DISCUSSION
Here we described the development of a human GABAB,
CHO-Gqi3 (5)-NFat, b-lactamase cell line for use in a high
throughput, calcium mobilization assay. The clonal cell line
displayed a sensitive dose dependent response to GABA and
demonstrated a robust signal-to-noise window excessive for
high throughput FLIPR screening. This assay will help identify
and characterize selective agonists, modulators, and antago-
nists of the GABAB receptor.
We used flow cytometry sorting along with the b-lacta-
mase technology to develop a high responding GABAB, cal-
cium signaling, clonal cell line. By linking b-lactamase to the
Figure 2. Blue Pool Sort. Dual parameter flow cytometric analysis
of cells loaded with CCF4 AM. CCF4 green fluorescence was
measured on the x-axis and CCF4 blue fluorescence on the y-axis.
Upper left-histogram: Wild-type CHOs representing no b-lacta-
mase activity. Upper right-histogram: The CHO GABAB cell line
treated with vehicle (negative control) demonstrating b-lactamase
background activity. Lower left-histogram: The CHO GABAB cell
line treated with 200 nM thapsigargin (positive control). Lower
right-histogram: The CHO GABAB cell line treated with 200 lM
GABA.
Figure 3. Single Cell Clone Sort. Dual parameter flow cytometric
analysis of cells loaded with CCF4 AM. CCF4 green fluorescence
was measured on the x-axis and CCF4 blue fluorescence on the y-
axis.Upper left-histogram:Wild-typeCHO’s representing no b-lacta-
mase activity. Upper right-histogram: The CHOGABAB cell line trea-
tedwith vehicle (negative control) demonstrating b-lactamase back-
groundactivity. Lower left-histogram: TheCHOGABAB cell line trea-
ted with 200 nM thapsigargin (positive control). Lower right-
histogram: The CHOGABAB cell line treatedwith 200 lMGABA.
Figure 4. FLIPR Analysis of the Sorted GABAB Clones. 10
expanded single cell clones and the blue-sorted pool were loaded
with Fluo-4 AM in a 384-well plate and analyzed on the FLIPR. The
clones were evaluated with the blue-sorted pool (x-axis) based on
agonist dose response using maximal fluorescence intensity (y-
axis). Clone-16 was identified and utilized in later studies and for
HTS assay development.
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calcium signaling pathway provided us with a direct method
to isolate a high responding calcium signaling clones. Sorting
high b-lactamase expressing clones correlated to high
responding calcium signaling clones on the FLIPR. Flow cyto-
metry sorting increases productivity of cell line development
efforts through the efficiencies of automated single-cell clon-
ing. Using CCF4 AM fluorescence as a marker for b-lactamase
activity, we were able to identify, sort, and isolate thousands of
cells per second based on a preferred phenotype or response.
Assays of transcriptional reporter genes are an important
tool for HTS. Novel cell lines that express a recombinant re-
ceptor, transcriptional response element, and a reporter gene
can be used to isolate clones used in a variety of assay types.
Flow cytometry sorting can be used to reduce high constitu-
tive activity, thus creating cell lines with superior signal-to-
noise ratios. Sorting can be used to isolate high responding
clones using calcium fluorescent indicators such as Indo-1
AM or Fluo-4 AM, although this is a much harder approach
than using the b-lactamase technology as CCF4 AM is an end-
point measurement which does not require additional instru-
mentation or manipulation of the cells on your flow cytometry
system.
We describe the creation of a truncated heterodimerized
GPCR stable cell line that can be used in both b-lactamase and
Figure 5. FLIPR Analysis of Clone-16: GABA Serial Dilution.
Clone-16 cells were loaded with Fluo-4 AM in a 384-well plate and
analyzed using the FLIPR. Fifteen thousand cells were seeded into
each well one day prior to the experiment and the response to
GABA is shown. Time is on the x-axis and fluorescence change
(counts) is on the y-axis. 25 nM GABA is shown in red. (A) 384
Multiwell Overlay. (B) Multiwell Average. 16 wells per concentra-
tion of GABA were measured, and means  standard deviation
are shown. GABA was added to the well 6 s after the initial read.
Figure 6. GABA EC50 calculation of Clone-16. Clone-16 cells were
loaded with Fluo-4 AM in a 384-well plate and analyzed using the
FLIPR. Fifteen thousand cells were seeded into each well one day
prior to the experiment and the average FLIPR well response to
GABA is shown. GABA concentration is on the x-axis and maxi-
mal fluorescence intensity is on the y-axis. GABA was added to
the well 6 s after the initial read. The GABA EC50 determination for
Clone-16 was 45.3 nM. Sixteen wells per concentration of GABA
were measured, and means  standard deviation are shown.
Figure 7. CGP54626 IC50 calculation of Clone-16. Clone-16 cells
were loaded with Fluo-4 AM in a 384-well plate and analyzed
using the FLIPR. Fifteen thousand cells were seeded into each
well one day prior to the experiment and the average FLIPR well
response to 100 nM GABA is shown. CGP54626 concentration is
on the x-axis and maximal fluorescence intensity is on the y-axis.
CGP54626 was added to the well 5 min prior to the GABA addition
to the well. The CGP54626 IC50 determination for Clone-16 was
3.57 nM. Sixteen wells per concentration of inhibitor were mea-
sured, and means  standard deviation are shown.
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FLIPR assays. This multiplex approach allows the researcher
to test compounds with either short term or long term expo-
sures. The cell line allows for the robust and consistent mea-
sure of calcium signaling using the FLIPR. The cell line con-
tains the truncated heterodimerized receptor, which allows for
the measurement of different types of ligands that can inhibit,
activate, or potentiate the receptor. The cell line contains the
NFat b-lactamase reporter gene which can measure down-
stream effects of the signaling pathway using CCF4 AM. The
calcium mobilization assay can be miniaturized to 1,536 on
the FLIPR and the b-lactamase assay can be miniaturized to
3,456 on a fluorescence plate reader.
The FLIPR calcium mobilization assay is the preferred
high throughput assay for GPCR drug screening. The FLIPR
can acquire data rapidly and can obtain consistent dose-
response curves from compound screening. When trying to
identify antagonists or modulators, the cells only interact with
compound for a few minutes. In the case of screening for ago-
nists, the cells only interact with compound for a few seconds.
This is a very important criterion not to be overlooked in
drug screening as some compounds will degrade or precipitate
in an aqueous environment. Generally, FLIPR data has tighter
CVs, robust signal-to-noise ratios and lower EC50s than other
assay types. The FLIPR calcium flux assay is the most popular
high throughput screening approach because it is a rapid and
a direct signal for biological activity of GPCRs.
ACKNOWLEDGMENTS
The authors thank Alison Donahue for her suggestions
and critical reading to improve the quality and clarity of the
manuscript.
LITERATURE CITED
1. Chen K, Li H, Ye N, Zhang J, Wang J. Role of GABAB receptors in GABA and baclo-
fen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro.
Brain Res Bull 2005;67:310–318.
2. Bowery NG, Doble A, Hill DR, Hudson AL, Shaw JS, Turnbull MJ, Warringon R.
Bicuculline-insensitive gaba receptors on peripheral autonomic nerve terminals. Eur
J Pharm 1981;71:53–70.
3. Bowery NG, Enna SJ. Aminobutyric acidB receptors: First of the functional metabo-
tropic heterodimers. J Pharmacol Exp Ther 2000;292:2–7.
4. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson
M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE,
Nagarathnam D, Noble SA, Branchek TA, Gerald C. GABA(B) receptors function as a
heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature
1988;396:674–679.
5. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI,
Enna SJ. International Union of Pharmacology XXXIII. Mammalian c aminobutyric
acidB receptors: structure and function. Pharmacol Rev 2002;54:247–264.
6. Pin JP, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B, Havlickova M, Blahos
J, Prezeau L, Rondard P. Activation mechanism of the heterodimeric GABAB receptor.
Biochem Pharmacol 2004;68:1565–1572.
7. Liu J, Maurel D, Etzol S, Brabet I, Ansanay H, Pin JP, Rondard P. Molecular determi-
nants involved in the allosteric control of agonist affinity in the GABAB receptor by
the GABAB2 subunit. J Biol Chem 2004;279:15824–15830.
8. Gee KR, Brown A, Chen W-N U, Bishop-Stewart J, Gray D, Johnson I. Chemical and
physiological characterization of fluo-4 Ca21-indicator dyes. Cell Calcium 2000;
27:97–106.
9. Schroeder KS, Neagle BD. FLIPR: A new instrument for accurate, high throughput
opitcal screening. J Biomol Screen 1996;1:75–80.
10. Hodder P, Mull R, Cassaday J, Berry K, Strulovici B. Miniaturization of intracellular
calcium functional assays to 1536-well plate format using a fluorometric imaging
plate reader. J Biomol Screen 2004;9:417–426.
11. Qureshi SA. b-lactamase: An ideal reporter system for monitoring gene expression in
live eukayotic cells. Biotech 2007;42:91–96.
12. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, Whitney M, Roe-
mer K, Tsien RY. Quantitation of transcription and clonal selection of single living
cells with b-lactamase as reporter. Science 1998;279:84–88.
13. Knapp T, Hare E, Feng L, Zlokarnik G, Negulescu P. Detection of b-lactamase re-
porter gene expression by flow cytometry. Cytometry 2003;51:68–78.
14. Coward P, Chan SD, Wada HG, Humphries GM, Conklin BR. Chimeric G-proteins
allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem
1999;270:242–248.
15. Yokoyama T, Kato N, Yamada N. Development of a high-throughput bioassay to
screen melatonin receptor agonists using human melatonin receptor expressing CHO
cells. Neurosci Lett 2003;344:45–48.
16. Kowal D, Nawoschik S, Ochalski R, Dunlop J. Functional calcium coupling with the
human metabotropic glutamate receptor subtypes 2 and 4 by stable co-expression
with a calcium pathway facilitating G-protein chimera in Chinese hamster ovary cells.
Biochem Pharm 2003;66:785–790.
TECHNICAL NOTE
766 GABAB Cell Line Development
